Prime Therapeutics Study Reveals Botox® is Highest Cost Therapy to Treat Certain Neurologic Conditions

Monday, September 23, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

Real-world use shows over $6 million savings potential switching from Botox® to lower cost therapies

 Contact:

Jenine Anderson

Public Relations Manager

612.777.5629

Jenine.Anderson@primetherapeutics.com



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Premium Membership Benefits

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store